The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "hip fracture"

Search results for: hip fracture

U.S. Hip Fracture Incidence Declines with Reductions in Smoking & Drinking

August 4, 2020 • By Lisa Rapaport

(Reuters Health)—Age-adjusted hip fracture incidence has declined in the U.S. over the past four decades, aided by a decline in smoking and alcohol consumption, a new study suggests. Researchers examined data on 4,918 men and 5,634 women who participated in the prospective Framingham Heart Study from 1970 to 2010. Overall, the age-adjusted incidence of hip… [Read More]

Filed Under: Conditions Tagged With: Alcohol, fracture risk, Fractures, hip fracture, Smoking

After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk

June 15, 2020 • By Lisa Rapaport

(Reuters Health)—Patients hospitalized for a hip fracture are less likely to experience a subsequent fracture-related hospitalization if they start anti-osteoporosis medication sooner, a Taiwanese study suggests.1 Researchers examined data on 77,930 patients aged 50 years and older hospitalized for hip fractures, including 9,986 people prescribed anti-osteoporosis medications within one year of the index fracture. Compared… [Read More]

Filed Under: Uncategorized Tagged With: drug treatment, Fractures, Osteoporosis, osteoporosis treatments

Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis

July 7, 2018 • By Anne Harding

NEW YORK (Reuters Health)—Levels of two bone markers currently recommended for evaluating postmenopausal women with osteoporosis have no association with hip fracture risk, according to a new study using Women’s Health Initiative data. “At least in these postmenopausal women, it was not a useful endeavor to check bone turnover markers to predict hip-fracture risk. That… [Read More]

Filed Under: Conditions Tagged With: bone markers, Fractures, hip fracture, hip fracture risk, Osteoporosis

Existing CT Scans as Good as DXA for Assessing Hip Fracture Risk

May 8, 2018 • By Scott Baltic

NEW YORK (Reuters Health)—A “biomechanical” analysis of a previously taken pelvic or abdominal computed tomography (CT) scan is at least as accurate in assessing an individual’s hip fracture risk as a dual-energy X-ray absorptiometry (DXA) scan, according to new research. This accuracy of the hip bone mineral density (BMD) T-score as measured by the biomechanical… [Read More]

Filed Under: Conditions Tagged With: computed tomography, CT scan, dual-energy X-ray absorptiometry scan, Osteoporosis, scan

Healthy Diet Linked to Lower Hip Fracture Risk in U.S. Women

March 4, 2018 • By Mary Gillis

(Reuters Health)—Eating an overall healthy diet is tied to a lower risk of hip fracture among women over age 50, a U.S. study suggests. Researchers analyzed decades’ worth of dietary and health data for more than 100,000 U.S. men and women. They found that women who scored highest on the American Healthy Eating Index-2010 (AHEI)… [Read More]

Filed Under: Conditions Tagged With: Diet, Fractures, healthy eating, hip fracture, hip fracture risk, Osteoporosis, postmenopausal women, Women

Hip Fractures Increasing in Older U.S. Women

January 16, 2018 • By Cheryl Platzman Weinstock

(Reuters Health)—The incidence of hip fractures in older women in the U.S. is rising after more than a decade of decline, according to a large new study of Medicare recipients. Hip fracture rates declined each year from 2002–2012, the researchers found. But starting in 2013, hip fracture rates leveled off and were higher than expected…. [Read More]

Filed Under: Conditions Tagged With: Fractures, hip, hip fracture, Medicare, older women, Osteoporosis, Women

Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab

December 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Bisphosphonate Drug Holidays Drug holidays are common for patients on bisphosphonate therapy. Often, these breaks in treatment are related to known U.S. Food and Drug Administration (FDA) warnings and drug class adverse effects. Currently, data on fracture risk related to drug holidays are limited. In recent research highlighted at the 2017 ACR/ARHP Annual Meeting ,… [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates, Spondyloarthritis Tagged With: Ankylosing Spondylitis, Approval, Bisphosphonate, bone loss, drug therapy, FDA, Fractures, Golimumab, hip, Osteoporosis, osteoporosis treatments, outcome, patient care, plaque psoriasis, Research, rheumatology, risk, Safety, ustekinumab, warning

Bisphosphonate Drug Holiday & Hip Fracture Risk

November 21, 2017 • By Michele B. Kaufman, PharmD, BCGP

New research found women on bisphosphonate therapy who take a drug holiday experience a higher rate of hip fracture…... [Read More]

Filed Under: Drug Updates Tagged With: Bisphosphonate, bisphosphonates, drug holiday, Fractures, hip, hip fracture, hip fracture risk, Osteoporosis, osteoporosis treatments

Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada

September 27, 2017 • By Michele B. Kaufman, PharmD, BCGP

Patients who receive abaloparatide and switch to alendronate have a statistically significant reduction in fracture risk through 3.5 years, according to a new study…... [Read More]

Filed Under: Biologics & Biosimilars, Drug Updates Tagged With: abaloparatide, alendronate, Biologics & Biosimilars, etanercept, etanercept-szzs, Fractures, hip, hip fracture, hip fracture risk

Alendronate Decreases Hip Fracture Risk in Older Patients Using Oral Prednisolone

August 21, 2017 • By Lara C. Pullen, PhD

New research found that older patients on prednisolone who are also treated with alendronate experience a significantly lower risk of hip fracture. Alendronate use was also associated with a lower risk of death…... [Read More]

Filed Under: Conditions Tagged With: alendronate, elderly, Fractures, hip fracture, hip fracture risk, prednisolone

  • 1
  • 2
  • 3
  • …
  • 25
  • Next Page »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)